ACRO Biomedical Co., Ltd. (TPEX:6748)
Taiwan · Delayed Price · Currency is TWD 64.90
+0.40 (0.62%)
Oct 31, 2025, 3:00 PM CST
ACRO Biomedical Market Cap
ACRO Biomedical has a market cap or net worth of 3.97 billion as of October 31, 2025. Its market cap has increased by 176.76% in one year.
Market Cap
3.97B
Enterprise Value
3.53B
Revenue
36.50M
Ranking
n/a
PE Ratio
n/a
Stock Price
64.90
Market Cap Chart
Since July 27, 2021, ACRO Biomedical's market cap has increased from 1.38B to 3.97B, an increase of 187.88%. That is a compound annual growth rate of 28.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 3.97B | 154.01% |
| Dec 31, 2024 | 1.56B | -35.07% |
| Dec 29, 2023 | 2.41B | 135.16% |
| Dec 30, 2022 | 1.02B | 9.09% |
| Dec 30, 2021 | 938.98M | -31.96% |
| Jul 27, 2021 | 1.38B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 233.43B |
| PharmaEssentia | 184.18B |
| Lotus Pharmaceutical | 77.71B |
| Bora Pharmaceuticals Co., LTD. | 77.08B |
| Lumosa Therapeutics | 35.38B |
| Oneness Biotech | 30.99B |
| Pegavision | 26.56B |
| Polaris Group | 26.43B |